DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
Anastasopoulou, Eleftheria A, Tzonis, Panagiotis, Fortis, Sotirios P, Mahaira, Louisa, Vaxevanis, Christoforos, Ardavanis, Alexandros, Mittendorf, Elizabeth A, Peoples, George E, Baxevanis, ConstantinVolume:
3
Année:
2015
Langue:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P427
Fichier:
PDF, 256 KB
english, 2015